DESNZ Stock Overview
Manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical industries worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Dottikon ES Holding AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 222.50 |
| 52 Week High | CHF 270.00 |
| 52 Week Low | CHF 209.00 |
| Beta | 1.13 |
| 1 Month Change | -5.72% |
| 3 Month Change | -14.09% |
| 1 Year Change | -3.16% |
| 3 Year Change | -24.83% |
| 5 Year Change | n/a |
| Change since IPO | 15.64% |
Recent News & Updates
Recent updates
Shareholder Returns
| DESNZ | GB Pharmaceuticals | GB Market | |
|---|---|---|---|
| 7D | 3.2% | -0.08% | 0.2% |
| 1Y | -3.2% | -3.3% | 2.3% |
Return vs Industry: DESNZ matched the UK Pharmaceuticals industry which returned -2.8% over the past year.
Return vs Market: DESNZ underperformed the UK Market which returned 2.7% over the past year.
Price Volatility
| DESNZ volatility | |
|---|---|
| DESNZ Average Weekly Movement | 3.1% |
| Pharmaceuticals Industry Average Movement | 6.1% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.4% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: DESNZ has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: DESNZ's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1913 | 770 | Markus Blocher | dottikon.com |
Dottikon ES Holding AG manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical industries worldwide. The company’s chemicals and intermediates include amines, anilines, azaindoles, benzimidazoles, benzoic acid derivatives, benzyl compounds, boron building blocks, chiral compounds, cyclohexane derivatives, cyclopropyl building blocks, indazoles, indoles, N-heterocycles, nitrate esters, nitroaromatic compounds, O-heterocycles, phenols and anisoles, and pyridine building blocks. It also offers Dottisol, an isosorbide dimethyl ether for application as a solubility enhancer in cosmetic, pharma, and agro products, as well as a performance additive in various industries.
Dottikon ES Holding AG Fundamentals Summary
| DESNZ fundamental statistics | |
|---|---|
| Market cap | CHF 3.05b |
| Earnings (TTM) | CHF 75.50m |
| Revenue (TTM) | CHF 337.39m |
40.4x
P/E Ratio9.0x
P/S RatioIs DESNZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DESNZ income statement (TTM) | |
|---|---|
| Revenue | CHF 337.39m |
| Cost of Revenue | CHF 126.19m |
| Gross Profit | CHF 211.20m |
| Other Expenses | CHF 135.71m |
| Earnings | CHF 75.50m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
May 28, 2025
| Earnings per share (EPS) | 5.46 |
| Gross Margin | 62.60% |
| Net Profit Margin | 22.38% |
| Debt/Equity Ratio | 14.2% |
How did DESNZ perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 18:02 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Dottikon ES Holding AG is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Carla Bänziger | Bank Vontobel AG |
| Daniel Jelovcan | Zürcher Kantonalbank |